Background:-Hypertension is the leading cause of cardiovascular disease worldwide. Recent reports In India reveals that Hypertension is a major risk factor for cardio vascular disease that killed 2.7 million people in 2004 and will results in the death of over 4 million people by 2030. If these people take effective lifestyle modification measures along with compliance to medication they can prevent severe complications of this disease. Materials And Methods:-The present cross sectional descriptive study was conducted with an aim to identify the Compliance Regarding Life Style Modifications in Preventing Complications among hypertensive patients.100 samples were included and data collected by interview method. Results:-The study results revealed that majority 63% of samples had non compliance on life style modification for hypertension and 37% of samples had compliance on life style modifications for hypertension. Conclusion:-The study concluded that there is an emerging need for educating the population regarding the need for prompt and effective life style modifications.
Background: Angiotensin converting enzyme inhibitor (ACEi) and beta-blocker (BB) medications are indicated in patients with impaired left ventricular (LV) systolic function. These medications result in improved prognosis, quality of life and LV function, with a proportion of complete recovery of LV systolic function. The proportion of patients who require life-long medication use for indications other than previous LV dysfunction is unclear.Methods: We conducted a retrospective analysis of 1400 cardiology patients treated at Princess Alexandra Hospital, Brisbane, up to 2014. Data collected include, patient demographics, medical history, medication use, imaging results and clinical outcomes.Results: 1400 cardiology medical records were evaluated. Significantly impaired LV systolic function (LV EF ≤ 40%) was noted in 559 patients (39.9%) at the beginning of their medical treatment, of which 173 patients had no coronary artery disease and were still alive in 12 months. In the nonischaemic cases, recovery of LV systolic function was noted in 27.7%, the majority of which had indications for ACEi and BB use other than previous cardiomyopathy. Only 18 out of 559 patients (3.2%) with history of LV impairment has previous non-ischaemic cardiomyopathy as sole indications for ongoing ACEi and BB use.
Conclusion:Only a very small proportion of patients have previous non-ischaemic cardiomyopathy as sole indication for on-going ACEi and BB use. Most other patients have additional disease indications for continuing these medications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.